AstraZeneca Loses Bid To Ban Seroquel MDL Expert

Law360, New York (June 19, 2009, 12:00 AM EDT) -- A judge in charge of multidistrict litigation over AstraZeneca's antipsychotic drug Seroquel has denied a request by the drugmaker to exclude the general causation testimony of an expert witness for plaintiffs.

Judge Anne C. Conway of the U.S. District Court for the Middle District of Florida ruled Thursday that the expert — epidemiologist Dr. Donna Arnett — could testify at the trial of federal court cases that Seroquel leads to “clinically significant and relevant metabolic risk,” including weight gain, insulin resistance and diabetes.

AstraZeneca filed a...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.